Home Newsfeeds Baird Maintains Neutral on Fleetcor Technologies, Raises Price Target to $230

Baird Maintains Neutral on Fleetcor Technologies, Raises Price Target to $230

Baird analyst David Koning maintains Fleetcor Technologies (NYSE:FLT) with a Neutral and raises the price target from $220 to $230.

byBenzinga Newsdesk

January 25, 2023

1 minute read

Baird analyst David Koning maintains Fleetcor Technologies (NYSE:FLT) with a Neutral and raises the price target from $220 to $230.

William Blair Initiates Coverage On NAPCO Security Techs with Outperform Rating

By Benzinga Newsdesk

March 8, 7:51 AM

William Blair analyst Matthew Pfau initiates coverage on NAPCO Security Techs (NASDAQ:NSSC) with a Outperform rating.

NSSC

G1 Therapeutics Q4 EPS $(0.73) Beats $(0.84) Estimate, Sales $10.30M Beat $9.65M Estimate

By Bill Haddad

March 1, 7:35 AM

G1 Therapeutics (NASDAQ:GTHX) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(0.84) by 13.1 percent. This is a 22.34 percent increase over losses of $(0.94) per share from

GTHX

News

Israeli Public Broadcasting Corp Amichai Stein Tweets “Social Media Accounts In Russia: Russian Railways And Airlines Are Refusing To Sell Tickets To Men 18-65 Years Of Age”

By Benzinga Newsdesk

September 21, 10:59 AM

https://twitter.com/AmichaiStein1

RSX

Wedbush Initiates Coverage On Trulieve Cannabis with Outperform Rating, Announces Price Target of $18

By Benzinga Newsdesk

December 2, 7:30 AM

Wedbush analyst Gerald Pascarelli initiates coverage on Trulieve Cannabis (OTC:TCNNF) with a Outperform rating and announces Price Target of $18.

TCNNF

Baird Maintains Neutral on Fleetcor Technologies, Raises Price Target to $230

Related Posts

William Blair Initiates Coverage On NAPCO Security Techs with Outperform Rating

G1 Therapeutics Q4 EPS $(0.73) Beats $(0.84) Estimate, Sales $10.30M Beat $9.65M Estimate

Israeli Public Broadcasting Corp Amichai Stein Tweets “Social Media Accounts In Russia: Russian Railways And Airlines Are Refusing To Sell Tickets To Men 18-65 Years Of Age”

Wedbush Initiates Coverage On Trulieve Cannabis with Outperform Rating, Announces Price Target of $18